R&D Pipeline for New Medicine
R&D_Pipeline
(
US,
China )
| Project code | Indication | Discovery | Preclinical | Phase1 | Phase2 | Phase3 | Partners | |
|---|---|---|---|---|---|---|---|---|
| Immunology | HL036 (tanfanercept) | Dry eye disease (DED) |
|
|
|
|
|
(China) |
| HL161 (batoclimab) | Myasthenia gravis (MG) |
|
|
|
|
(US/EU) (China) |
||
| Thyroid eye disease (TED) |
|
|
|
|
(US/EU) (China) |
|||
| Warm autoimmune hemolytic anemia (WAIHA) |
|
|
|
|
(US/EU) |
|||
| Neuromyelitis optica (NMO) |
|
|
|
|
(China) |
|||
| Immune thrombocytopenia (ITP) |
|
|
|
|
(China) |
|||
| HL189 (tanfanercept) | Non-Infectious uveitis(NIU) |
|
|
|||||
| Oncology | HL186/HL187 | Immuno-oncology |
|
|